Rather than focus on this important indicator, the market focuses on predictions of a double dip by distant Wall Street economists, who are not on the lots selling trucks.
David Flum, a surgeon at the University of Washington who focuses on orthopedics, says there is a "tremendous double standard" in what the FDA requires of drugs versus devices.